Literature DB >> 2986521

Feline leukaemia viruses: molecular biology and pathogenesis.

J C Neil, D E Onions.   

Abstract

The feline leukaemia virus (FeLV) group represents one of the most important viral pathogens of the domestic cat. In addition, this virus - host system is one of the major experimental models for retroviral pathogenesis. Under natural conditions, the virus is horizontally transmitted through the cat population. The outcome of infection depends on a variety of factors including the virus does encountered and the age and immune status of the host. FeLVs can establish persistent infection, either overt or latent. Degenerative diseases of the haemopoietic system are the most common result of persistent infection and immunosuppression with secondary infection accounts for more deaths than does neoplastic disease. However, more is known about the molecular mechanisms of oncogenesis in this system and there are now numerous examples of field case tumours where FeLV has transduced an oncogene or acted as an insertional mutagen. The factors affecting the relative frequency of these mechanisms are considered as is the possibility that recombinant env gene recombinants play a role in FeLV pathogenesis.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2986521

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  9 in total

Review 1.  Feline leukemia virus: current status of the feline induced immune depression and immunoprevention.

Authors:  R G Olsen; M G Lewis; L J Lafrado; L E Mathes; K Haffer; R Sharpee
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

2.  The p12I, p13II, and p30II proteins encoded by human T-cell leukemia/lymphotropic virus type I open reading frames I and II are localized in three different cellular compartments.

Authors:  I J Koralnik; J Fullen; G Franchini
Journal:  J Virol       Date:  1993-04       Impact factor: 5.103

3.  Inhibition of phorbol ester-induced neutrophil chemiluminescence by FeLV.

Authors:  C S Dezzutti; L J Lafrado; M G Lewis; R G Olsen
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

4.  In vitro and in vivo evidence that the antiviral activity of 2',3'-dideoxycytidine is target cell dependent in a feline retrovirus animal model.

Authors:  P J Polas; C L Swenson; R Sams; C M Cheney; K A Hayes; M J Tarr; G J Kociba; L E Mathes
Journal:  Antimicrob Agents Chemother       Date:  1990-07       Impact factor: 5.191

5.  Longitudinal analysis of feline leukemia virus-specific cytotoxic T lymphocytes: correlation with recovery from infection.

Authors:  J Norman Flynn; Stephen P Dunham; Vivien Watson; Oswald Jarrett
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

6.  Identification of a putative receptor for subgroup A feline leukemia virus on feline T cells.

Authors:  A K Ghosh; M H Bachmann; E A Hoover; J I Mullins
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

Review 7.  Important mammalian veterinary viral immunodiseases and their control.

Authors:  J R Patel; J G M Heldens; T Bakonyi; M Rusvai
Journal:  Vaccine       Date:  2012-01-17       Impact factor: 3.641

Review 8.  Haematological disorders associated with feline retrovirus infections.

Authors:  M L Linenberger; J L Abkowitz
Journal:  Baillieres Clin Haematol       Date:  1995-03

Review 9.  Immune mechanisms in the pathogenesis of viral diseases: a review.

Authors:  G Trautwein
Journal:  Vet Microbiol       Date:  1992-11       Impact factor: 3.293

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.